Alzheon Inc - Ordinary Shares Stock Price (ALZH)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Prestige Consumer Healthcare Inc. (PBH) CEO Ron Lombardi on Q4 2021 Results - Earnings Call TranscriptSat, 8 May 2021 00:22:06 UTC via Seeking Alpha
Prestige Consumer Healthcare Inc. 2021 Q4 - Results - Earnings Call PresentationFri, 7 May 2021 22:56:54 UTC via Seeking Alpha
Diversified Healthcare Trust (DHC) Management on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 20:42:02 UTC via Seeking Alpha
Community Healthcare Trust, Inc. (CHCT) CEO Tim Wallace on Q1 2021 Results - Earnings Call TranscriptFri, 7 May 2021 11:49:07 UTC via Seeking Alpha
HCA Is A Unique Healthcare PlayThu, 6 May 2021 16:50:08 UTC via Seeking Alpha
Tile Shop Holdings: Near-Term Catalysts To Drive Shares Back To The Double DigitsThu, 6 May 2021 11:56:20 UTC via Seeking Alpha
Vaccine Makers’ Shares Fall as U.S. Backs Patent WaiverThu, 6 May 2021 09:53:10 UTC via Yahoo Finance
Kellogg shares rise after guidance raisedThu, 6 May 2021 08:46:52 UTC via Yahoo Finance
Cardinal Health shares slide 8.8% premarket after earnings fall short of esimatesThu, 6 May 2021 07:21:55 UTC via Yahoo Finance
Nio Makes Norway Entry Official, Shares Details On Local Team, Infrastructure, Service And Vehicle ModelsThu, 6 May 2021 07:00:17 UTC via Yahoo Finance

Alzheon Inc - Ordinary Shares Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:ALZH

You don't have any alerts set for IEX:ALZH.

About Alzheon Inc - Ordinary Shares

Alzheon Inc operates as a clinical-stage biopharmaceutical company. It is engaged in developing drugs and devices to treat Alzheimer's disease and other neurological disorders.

CEOMartin Tolar IndustryBiotechnology SectorHealthcare Websitehttp://www.alzheon.com Issue ExchangeNASDAQ Capital Market Issue TypeUnknown

Real-time ALZH to USD Trade Analysis on IEX

Market Status Closed

Analysis is available when the exchange & market are open.